Pharma Journalist 9038 posts 0 comments

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19…
Read More...

Extractables and Leachables USA Online is taking place October 26-28, 2020. The three day event includes sessions that are crucial to the extractables and leachables industry,…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for branaplam (LMI070) in Huntington’s disease (HD). An Orphan Drug Designation…
Read More...

Teneobio, Inc., a clinical-stage biotechnology company developing engineered bispecific antibodies to treat cancer, announced that it has entered into a research collaboration and…
Read More...

Gilead Sciences, Inc. announced 48-week data from the BRAAVE 2020 study, a Phase 3 clinical trial evaluating the safety and efficacy of switching to Biktarvy (bictegravir 50…
Read More...

ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. a clinical-stage, natural killer cell-based therapeutics company, announced that the first patient has been…
Read More...

Purdue Pharma L.P. announced that it has entered into an agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the…
Read More...

HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has entered into a research collaboration and service agreement with Takeda Pharmaceutical Company…
Read More...

JSR Life Sciences, LLC announced that it is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its…
Read More...

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of ASP0367/MA-0211 (“ASP0367”) as a potential…
Read More...